89 related articles for article (PubMed ID: 29757003)
1. Transglutaminase 2 Mediates the Cytotoxicity of Resveratrol in a Human Cholangiocarcinoma and Gallbladder Cancer Cell Lines.
Roncoroni L; Elli L; Braidotti P; Tosi D; Vaira V; Tacchini L; Lombardo V; Branchi F; Scricciolo A; Doneda L
Nutr Cancer; 2018 Jul; 70(5):761-769. PubMed ID: 29757003
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol inhibits cell growth in a human cholangiocarcinoma cell line.
Roncoroni L; Elli L; Dolfini E; Erba E; Dogliotti E; Terrani C; Doneda L; Grimoldi MG; Bardella MT
Liver Int; 2008 Dec; 28(10):1426-36. PubMed ID: 18397227
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 expression levels regulate sensitivity to cystamine plus TRAIL-mediated apoptosis.
Jang JH; Park JS; Lee TJ; Kwon TK
Cancer Lett; 2010 Jan; 287(2):224-30. PubMed ID: 19632032
[TBL] [Abstract][Full Text] [Related]
4. Effect of histone deacetylase inhibitor on proliferation of biliary tract cancer cell lines.
Xu LN; Wang X; Zou SQ
World J Gastroenterol; 2008 Apr; 14(16):2578-81. PubMed ID: 18442209
[TBL] [Abstract][Full Text] [Related]
5. Role of tissue transglutaminase in age-associated ventricular stiffness.
Oh YJ; Pau VC; Steppan J; Sikka G; Bead VR; Nyhan D; Levine BD; Berkowitz DE; Santhanam L
Amino Acids; 2017 Mar; 49(3):695-704. PubMed ID: 27438265
[TBL] [Abstract][Full Text] [Related]
6. Cystamine and Disulfiram Inhibit Human Transglutaminase 2 via an Oxidative Mechanism.
Palanski BA; Khosla C
Biochemistry; 2018 Jun; 57(24):3359-3363. PubMed ID: 29570977
[TBL] [Abstract][Full Text] [Related]
7. Transglutaminase type 2 in human abdominal aortic aneurysm is a potential factor in the stabilization of extracellular matrix.
Shin S; Cho YP; Jun H; Park H; Hong HN; Kwon TW
J Vasc Surg; 2013 May; 57(5):1362-70. PubMed ID: 23538006
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells.
Thongchot S; Ferraresi A; Vidoni C; Loilome W; Yongvanit P; Namwat N; Isidoro C
Cancer Lett; 2018 Aug; 430():160-171. PubMed ID: 29802929
[TBL] [Abstract][Full Text] [Related]
9. Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.
Munezane T; Hasegawa T; Suritala ; Tanaka A; Okada K; Okita Y
J Vasc Surg; 2010 Oct; 52(4):967-74. PubMed ID: 20615646
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Transglutaminase 2 activity increases cisplatin cytotoxicity in a model of human hepatocarcinoma chemotherapy.
Meshram DD; Pike CVS; Coussons PJ
Eur J Pharmacol; 2017 Nov; 815():332-342. PubMed ID: 28943101
[TBL] [Abstract][Full Text] [Related]
11. Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase.
Mishra S; Murphy LJ
J Biol Chem; 2004 Jun; 279(23):23863-8. PubMed ID: 15069073
[TBL] [Abstract][Full Text] [Related]
12. Role of transglutaminase 2 in PAC
Algarni AS; Hargreaves AJ; Dickenson JM
Biochem Pharmacol; 2017 Mar; 128():55-73. PubMed ID: 28065858
[TBL] [Abstract][Full Text] [Related]
13. Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions.
Badarau E; Wang Z; Rathbone DL; Costanzi A; Thibault T; Murdoch CE; El Alaoui S; Bartkeviciute M; Griffin M
Chem Biol; 2015 Oct; 22(10):1347-61. PubMed ID: 26456735
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis of human cholangiocarcinoma cell lines induced by β-escin through mitochondrial caspase-dependent pathway.
Shen DY; Kang JH; Song W; Zhang WQ; Li WG; Zhao Y; Chen QX
Phytother Res; 2011 Oct; 25(10):1519-26. PubMed ID: 21394804
[TBL] [Abstract][Full Text] [Related]
15. β
Vyas FS; Nelson CP; Freeman F; Boocock DJ; Hargreaves AJ; Dickenson JM
Eur J Pharmacol; 2017 Oct; 813():105-121. PubMed ID: 28754379
[TBL] [Abstract][Full Text] [Related]
16. A polysaccharide from Pinellia ternata inhibits cell proliferation and metastasis in human cholangiocarcinoma cells by targeting of Cdc42 and 67kDa Laminin Receptor (LR).
Li Y; Li D; Chen J; Wang S
Int J Biol Macromol; 2016 Dec; 93(Pt A):520-525. PubMed ID: 27576948
[TBL] [Abstract][Full Text] [Related]
17. Natural compound oblongifolin C inhibits autophagic flux, and induces apoptosis and mitochondrial dysfunction in human cholangiocarcinoma QBC939 cells.
Zhang A; He W; Shi H; Huang X; Ji G
Mol Med Rep; 2016 Oct; 14(4):3179-83. PubMed ID: 27499017
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
[TBL] [Abstract][Full Text] [Related]
19. Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.
Carbone C; Di Gennaro E; Piro G; Milone MR; Pucci B; Caraglia M; Budillon A
Amino Acids; 2017 Mar; 49(3):517-528. PubMed ID: 27761756
[TBL] [Abstract][Full Text] [Related]
20. A1 adenosine receptor-induced phosphorylation and modulation of transglutaminase 2 activity in H9c2 cells: A role in cell survival.
Vyas FS; Hargreaves AJ; Bonner PL; Boocock DJ; Coveney C; Dickenson JM
Biochem Pharmacol; 2016 May; 107():41-58. PubMed ID: 27005940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
